Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ANT2 drives proinflammatory macrophage activation in obesity
Jae-Su Moon, … , Chanond A. Nasamran, Yun Sok Lee
Jae-Su Moon, … , Chanond A. Nasamran, Yun Sok Lee
Published October 22, 2021
Citation Information: JCI Insight. 2021;6(20):e147033. https://doi.org/10.1172/jci.insight.147033.
View: Text | PDF
Research Article Endocrinology Metabolism

ANT2 drives proinflammatory macrophage activation in obesity

  • Text
  • PDF
Abstract

Macrophage proinflammatory activation is an important etiologic component of the development of insulin resistance and metabolic dysfunction in obesity. However, the underlying mechanisms are not clearly understood. Here, we demonstrate that a mitochondrial inner membrane protein, adenine nucleotide translocase 2 (ANT2), mediates proinflammatory activation of adipose tissue macrophages (ATMs) in obesity. Ant2 expression was increased in ATMs of obese mice compared with lean mice. Myeloid-specific ANT2-knockout (ANT2-MKO) mice showed decreased adipose tissue inflammation and improved insulin sensitivity and glucose tolerance in HFD/obesity. At the molecular level, we found that ANT2 mediates free fatty acid–induced mitochondrial permeability transition, leading to increased mitochondrial reactive oxygen species production and damage. In turn, this increased HIF-1α expression and NF-κB activation, leading to proinflammatory macrophage activation. Our results provide a previously unknown mechanism for how obesity induces proinflammatory activation of macrophages with propagation of low-grade chronic inflammation (metaflammation).

Authors

Jae-Su Moon, Flavia Franco da Cunha, Jin Young Huh, Alexander Yu Andreyev, Jihyung Lee, Sushil K. Mahata, Felipe C.G. Reis, Chanond A. Nasamran, Yun Sok Lee

×

Figure 4

ANT2 is necessary for the metabolic activation of macrophages.

Options: View larger image (or click on image) Download as PowerPoint
ANT2 is necessary for the metabolic activation of macrophages.
(A) mRNA ...
(A) mRNA expression of proinflammatory genes in BMDMs treated with or without high glucose–primed 3T3-L1 adipocyte–conditioned media (ACM) for 24 hours (n = 4 wells/group). (B) mRNA expression of inflammatory genes in WT and ANT2-MKO BMDMs before and 9 and 24 hours after PA treatment (n = 2 wells/group). (C) Western blot analysis of inflammatory pathways in WT and ANT2-MKO BMDMs treated with or without PA or LPS for 30 minutes. Relative band intensity is plotted on the right. (D) mRNA expression of Hif1a and Hif2a in WT and ANT2-MKO BMDMs before and 9 and 24 hours after LPS treatment (n = 2 wells/group). (E) mRNA expression of Hif1a and Hif2a in WT and ANT2-MKO BMDMs before and 9 and 24 hours after PA treatment (n = 2 wells/group). (F) Western blot analysis of TLRs in WT and ANT2-MKO BMDMs (n = 2 wells/group). (G) Phagocytosis assays in WT and ANT2-MKO BMDMs (n = 6 wells/group). (H) Efferocytosis assays in WT and ANT2-MKO BMDMs (n = 7 wells/group). Microscopic images were taken under ×20 magnification. All values are mean ± SEM. *P < 0.05; **P < 0.01. Statistical analysis was performed by 2-tailed, unpaired t test (H) or 1-way (A and G) or 2-way (B and D) ANOVA with Tukey’s multiple comparison test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts